28 C
Vientiane
Thursday, October 23, 2025
spot_img
Home Blog

Taskforce Launches Fundraising Campaign to Combat COVID-19

0

The Lao Government has opened a donation channel for all those looking to contribute financially to the fight against the outbreak of COVID-19.

Dah Sing Bank New Personal Loan Plan with Ultra-Low Interest Rates

Extra HKD200 Supermarket Coupon for New-to-Bank Customers


HONG KONG SAR – Media OutReach Newswire – 23 October 2025 – To help customers take advantage of the low interest rate environment, Dah Sing Bank, Limited (“Dah Sing Bank” or “The Bank”) continues to support customers in planning their finances with greater flexibility with its personal loan offers. Through its personal loan offerings – Express Money and Credit Mastermind Instalment Loan – customers can access loan amounts of up to HKD2,000,000. These offerings provide customers with enhanced financial flexibility to enjoy new life experiences.

Express Money: Low Interest Rates for Fresh Life Experiences
Dah Sing Bank is committed to supporting the diverse financial needs of its customers. Whether upgrading equipment, home renovation, planning overseas education for children or covering other personal expenses, Express Money offers flexible solutions. With an attractive APR as low as 1.68%* and a repayment period of up to 60 months, customers can enjoy greater possibilities and fresh experiences at a low cost. Eligible applicants of Express Money may enjoy a cash rebate of up to HKD13,888 upon meeting the specified conditions.

Credit Mastermind Instalment Loan: Substantial Loan Amount for Debt-Free Living in as Fast as 24 Hours
Designed for credit card debt consolidation, Credit Mastermind Instalment Loan offers a substantial loan amount with approval and disbursement in as fast as 24 hours. With a monthly flat rate as low as 0.11%, customers can pay off all outstanding card balances in one go, instantly easing financial pressure and starting fresh. Eligible applicants may also receive a cash rebate of up to HKD18,000 upon meeting the specified conditions.

New-to-bank customers who successfully apply for Express Money or Credit Mastermind Instalment Loan and submit the required documents between now and 31 December 2025 will receive an extra reward of HKD200 supermarket cash coupons.

*An APR is a reference rate which includes the basic interest rate and other fees and charges of a product expressed as an annualized rate.
To borrow or not to borrow? Borrow only if you can repay!
The service(s) / product(s) mentioned herein is / are not targeted at customers in the EU.
The above service(s) / product(s) are subject to relevant terms and conditions. For details, please visit Dah Sing Bank website.

Hashtag: #DahSingBank

The issuer is solely responsible for the content of this announcement.

About Dah Sing Bank

Dah Sing Bank, Limited (the “Bank”) is a wholly-owned subsidiary of Dah Sing Banking Group (HKG:2356). Founded in Hong Kong over 75 years ago, the Bank has been providing quality banking products and services to its customers with a vision to be “The Local Bank with a Personal Touch”. Over the years, the Bank has been rigorous in delivering on its brand tagline to grow with its customers in Hong Kong, the Greater Bay Area and beyond – “Together We Progress and Prosper”. Building on our experience and solid foundation in the industry, our scope of professional services now spans retail banking, private banking, business and commercial banking. Meanwhile, the Bank is also making significant investments in its digital banking capabilities to stay abreast with smart banking developments in Hong Kong and to support financial inclusion at large.

In addition to its Hong Kong banking operations, the Bank has wholly-owned subsidiaries including Dah Sing Bank (China) Limited, Banco Comercial de Macau, S.A., and OK Finance Limited. It is also a strategic shareholder of Bank of Chongqing with a shareholding of about 13%. Dah Sing Bank and its subsidiaries now have 63 operating locations in Hong Kong, Macau and Chinese Mainland.

DXC Appoints Anthony Pappas as Chief Marketing Officer to Lead Next Phase of Brand Transformation

ASHBURN, Va., Oct. 23, 2025 /PRNewswire/ — DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the appointment of Anthony Pappas as Chief Marketing Officer, reporting directly to President and CEO Raul Fernandez.

DXC Appoints Anthony Pappas as Chief Marketing Officer to Lead Next Phase of Brand Transformation
DXC Appoints Anthony Pappas as Chief Marketing Officer to Lead Next Phase of Brand Transformation

Over the past six months, Anthony has played a pivotal role in redefining DXC’s brand for the future, helping to shape the company’s new identity and market positioning. Previously serving as Vice President of Business Leadership, he has now been appointed to lead DXC’s global marketing organization, building a high-performance, data-driven function focused on demand generation and close alignment with Sales Enablement.

“Anthony has been instrumental in reshaping how DXC shows up in the marketplace,” said Raul Fernandez, President and CEO, DXC Technology. “He brings more than 30 years of global marketing experience and a proven ability to build high-performing teams that link brand storytelling to measurable business results. Under his leadership, DXC is well positioned to expand its market presence and accelerate innovation in AI-driven enterprise solutions.”

Before joining DXC, Anthony held several board roles and advised customers as a fractional Chief Marketing Officer and Chief Creative Officer. He previously served as President and Chief Creative Officer of DMI’s Global Brand Marketing and Customer Experience division, transforming it into the company’s top-performing profit center. Earlier in his career, Anthony founded Pappas Group, a full-service creative agency, which he built from the ground up and successfully sold to DMI. Under his leadership, Pappas Group worked with leading brands including AARP, Discovery Channel, Hilton, Toyota, Under Armour, and Volkswagen.

“I’m honored to step into the role of CMO at such a transformative time for DXC,” said Anthony Pappas, Chief Marketing Officer. “We’re redefining our brand around the power of AI to deliver real business outcomes for our customers. I look forward to amplifying DXC’s innovation story and helping the world’s leading enterprises achieve more through partnership with DXC.”

About DXC Technology 

DXC Technology (NYSE: DXC) is a leading global provider of information technology services. We’re a trusted operating partner to many of the world’s most innovative organizations, building solutions that move industries and companies forward. Our engineering, consulting and technology experts help clients simplify, optimize and modernize their systems and processes, manage their most critical workloads, integrate AI-powered intelligence into their operations, and put security and trust at the forefront. Learn more on dxc.com.

 

Yili Wins Two IDF Dairy Innovation Awards at the World Dairy Summit

SANTIAGO, Chile, Oct. 23, 2025 /PRNewswire/ — Themed “Nourishing a Sustainable World,” the 2025 World Dairy Summit was held from October 20 to 23 in Santiago, Chile. Organized by the International Dairy Federation (IDF), the summit brought together industry representatives, experts, scholars, and organizations from the global dairy industry to explore new pathways for innovation and sustainability.

At the event, Yili’s booth—blending elements of Chinese culture with the spirit of the Chilechuan grassland—showcased the company’s flagship products, including liquid milk, milk powder, yogurt, and cheese.

From October 19 to 23, Yili Group representatives were engaged with the event’s full agenda. Liu Chunxi, Senior Executive President of Yili Group, was invited to the meeting of the IDF Task Force on the Paris Dairy Declaration on Sustainability; Dr. Yun Zhanyou, Vice President of Yili Group, was re-elected to the IDF Board; Ignatius Szeto, Assistant President of Yili Group, delivered a keynote speech titled “The Role of Dairy Consumption in Healthy Aging.”

Liu Chunxi delivers a speech at the World Dairy Summit
Liu Chunxi delivers a speech at the World Dairy Summit

Yili Representative re-elected to the IDF Board

At the IDF Board of Directors meeting held on October 19, Dr. Yun Zhanyou, Vice President of Yili Group, was re-elected for a new two-year term in recognition of his outstanding contributions to shaping global dairy policies, deepening international collaboration, and fostering closer dialogue between China’s dairy sector and the global industry.

Dr. Yun Zhanyou re-elected to the IDF Board
Dr. Yun Zhanyou re-elected to the IDF Board

Dr. Yun stated at the meeting, “I wish to express my gratitude to IDF and all member country representatives for their trust. I look forward to continuing to work hand in hand with global dairy colleagues to advance the industry’s higher-quality development.”

Yili recognized with IDF Dairy Innovation Awards

The IDF Dairy Innovation Awards are among the most influential and widely recognized accolades in the industry. This year, Yili received five nominations, leading its global peers. At the awards ceremony on October 21, Yili secured two awards for its outstanding innovation and sustainability practices.

Yili’s Xinhuo Bone Energy Formula Milk Powder received the Innovation in Dairy Products for Human Nutrition award. AMBPOMIAL’s “For a Bluer Ocean” Limited-Edition Eco-Packaging received the Innovation in Packaging and Transparency for Dairy Products award.

Yili honored with 2025 IDF Dairy Innovation Awards
Yili honored with 2025 IDF Dairy Innovation Awards

Laurent Damiens, Chair of the judging committee for the IDF Dairy Innovation Awards, presented Yili with the trophy and certificate. He noted that this marked the fourth consecutive year Yili has received the awards and commended the company for its strong innovation capabilities and global industry leadership.

In recent years, Yili has been recognized consistently at the IDF Dairy Innovation Awards. These honors span multiple fields, including product innovation, sustainable packaging, food safety and quality management, consumer nutrition, women’s empowerment, sustainable agriculture and climate action, as well as marketing and communication.

Looking ahead, Yili will further deepen collaboration with global partners to jointly build a resilient and sustainable global dairy ecosystem, thereby advancing the vision of “World Integrally Sharing Health.”

MGI Tech partners with Eva Holding Group to enhance the accuracy of disease monitoring

SÃO PAULO, Oct. 23, 2025 /PRNewswire/ — MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing essential tools and technologies to drive innovation in the life sciences, has entered into a strategic partnership with Eva Holding Group, a Brazilian group operating in genomics applied to human health, animal health, and agribusiness. The initiative aims to expand Brazilian patients’ access to genomics, including joint efforts in the development of the country’s genetic sector.

DNBSEQ-T7
DNBSEQ-T7

The agreement includes the installation of genetic sequencers that expand public access to cutting-edge genomic technologies and enhance the accuracy of cancer disease tracking, such as the DNBSEQ-T7, a high-performance system that has already been used in Brazil’s largest genomic sequencing project. This is the first T7 with IVD (In Vitro Diagnostic) certification sold in Latin America and the first and only IVDI-certified high throughput equipment in Brazil, meaning that, for the first time, the country has access to this technology for clinical use, in addition to its previous use for research.

“The DNBSEQ-T7 is a high-performance sequencer that combines large processing capacity with flexibility for multiple applications, including whole-genome, exome, and transcriptome sequencing. Its DNBSEQ™ technology delivers high-quality data at low cost,” says Carlos Carpio, Senior Commercial Director for MGI Latin America and General Manager of MGI in Brazil.

With its high performance, the DNBSEQ-T7 enables the resolution of complex genomic structures and the filling of gaps in genome assemblies, delivering deeper and more continuous DNA analysis. This technology contributes to the generation of more comprehensive data, improves the final quality of genome assemblies, supports accurate variant detection, and provides a broader view of the genetic profile.

Eva Holding Group comprises four brands focused on different segments, all with DNA as a central tool: 
– Predictus Gene – focused on human predictive analysis through whole genome sequencing (WGS). 
– OLLIN – dedicated to the clinical diagnosis of rare diseases. 
– Pet Nex – specialized in genetic analysis for pets. 
– Earth Biome – focused on genomics applied to livestock and agriculture.

“MGI is now our main partner in bringing cutting-edge genetic sequencing technology. This collaboration represents another important step in innovation with real impact, especially benefiting oncology patients, rare diseases, and neonatal screening, through the 72-hour Genome,” state Dr. Rene Pimenta da Silva Junior, CEO of OLLIN Análises Genômicas, and Dr. Carolina A. Barbosa, President of Eva Holding Group.

As part of its strategy, the group will centralize its high-complexity genomic operations in a technology park, ensuring greater efficiency, quality control, and scalability in its projects.

Genetic sequencing: an ally of precision medicine

Genetic sequencing plays a critical role in screening for various types of cancer, helping to identify genes associated with disease development. With a higher level of precision, doctors can recommend more effective and personalized treatments, leading to better clinical outcomes and increased patient survival rates.

Moreover, in cases of hereditary cancer where there is a genetic predisposition to disease development, technology can support predictive medicine and enable preventive measures.

“Understanding the risks of certain diseases enables the adoption of more assertive prevention strategies, as well as the comparison of therapeutic options to select those with the highest likelihood of a positive response, based on each patient’s genetic history,” concludes Carlos Carpio.

About MGI

MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology.

We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and has established research, manufacturing, training, and after-sales service facilities globally.

MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future.

Learn more at: https://en.mgi-tech.com/, LinkedIn, X and YouTube.

About Eva Holding Group

Eva Holding Group is an integrated genomics and biotechnology platform operating in human health, animal health, and agribusiness, always with a focus on the practical application of DNA as a transformative tool. With national presence and global strategic partnerships, the group brings together research, innovation, and clinical services in a unique ecosystem, offering cutting-edge solutions in diagnostics, personalized medicine, predictive genomics, preventive healthcare, and applied biotechnology.

Through its brands – Predictus Gene, OLLIN, Pet Nex, and Earth Biome – Eva Holding Group positions itself as a key player in building the future of precision medicine and applied genomics, combining technology, science, and large-scale social impact.

FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease

TAIPEI, Oct. 23, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track Designation for AJ201, the first-in-class for therapy for spinal and bulbar muscular atrophy (SBMA, also known as Kennedy’s disease).

“Receiving the Fast Track Designation for AJ201 marks a significant milestone for AnnJi,” said Dr. Wendy Huang, CEO and Chairperson of the Board of AnnJi. “Alongside the Orphan Drug Designations granted by both the U.S. FDA and EMA, this recognition reinforces AJ201’s potential to address the unmet needs of patients with SBMA. Backed by a strong global patent portfolio, we remain committed to advancing AJ201 into Phase 3 development and to working closely with the FDA to potentially deliver the first approved treatment for SBMA in more than two decades.”

About SBMA and AJ201

SBMA, or Kennedy’s disease, is a rare X-linked inherited neuromuscular disorder caused by CAG repeat expansion in the androgen receptor (AR) gene. The resulting mutant AR protein contributes to muscle and neuron degeneration through mechanisms involving cellular toxicity, oxidative stress, and neuroinflammation. SBMA affects ~1 in 40,000 males globally and currently has no FDA-approved treatment.

AJ201, also known as JM17, is a novel investigational compound that has shown potential in reducing mutant AR toxicity and improving motor function in preclinical SBMA models. At the molecular level, it promotes degradation of pathogenic mAR protein, induces expression of antioxidant enzymes, proteasome subunits, and heat shock proteins, all of which may slow disease progression (Bott et al., 2016).

About AnnJi Pharmaceutical

AnnJi Pharmaceutical Co., Ltd. (TWSE: 7754) is a clinical-stage drug development company focused on the development of innovative small molecules (NCEs). The company is dedicated to addressing high unmet medical needs in the fields of neurology, dermatology, and immune-inflammatory diseases, including rare diseases, such as Kennedy’s disease (SBMA) and Idiopathic Pulmonary Fibrosis (IPF).

AnnJi is committed to develop innovative therapies that improve the quality of life for patients suffering from neglected chronic diseases. We focus on advancing high-quality, differentiated, and innovative drug candidates, and collaborating with global pharmaceutical partners. Upon achieving proof-of-concept in phase II clinical trials, we aim to out-license our products for further co-development and commercialization, with the goal of bringing them to global markets and driving sustainable growth for the company.

Contact:

Anne Yu; anne.yu@ajpharm.com

Regal Rexnord Showcases Sustainable Air Movement Innovations for Data Centers at Data Centre World Asia 2025

Nicotra Gebhardt™ and COPRA™ Fans Lead the Next Generation of Energy-Efficient Cooling Solutions across Asia Pacific

SINGAPORE, Oct. 23, 2025 /PRNewswire/ — Following its successful showcase at Data Centre World Asia 2025, Regal Rexnord Corporation reaffirmed its commitment to driving sustainable innovation in the data center sector through its flagship family brand Nicotra Gebhardt™, a global leader in ventilation and air movement technology for more than 60 years.

Nicotra Gebhardt™ booth at Data Centre World Asia 2025
Nicotra Gebhardt™ booth at Data Centre World Asia 2025

At Data Centre World Asia 2025, our mission was to demonstrate how Regal Rexnord can support data centers in balancing growth with sustainability,” said Jane Yang, Vice President and General Manager of Power Efficiency Solutions (PES) Asia Pacific.

Among the featured technologies was the COPRA™ EC plug fan, an advanced ventilation system designed with 3D aerodynamic technology that achieves over 71% efficiency while reducing space and energy consumption by up to 40%. Nicotra Gebhardt™also showcased the Fan Filter Unit (FFU) for cleanroom environments and the Columbus™ high-efficiency axial fan, optimized for energy storage and low-noise thermal management applications.

With growing demand for reliable and energy-efficient ventilation, Nicotra Gebhardt™ continues to expand its presence in key Data Center applications across the region. The company’s advanced EC plug-fan technology, including the COPRA™ series, is designed to optimize airflow management, reduce total power usage effectiveness (PUE), and support customer’s long-term sustainability goals in both new builds and retrofit projects.

COPRA™ EC Plug Fans
COPRA™ EC Plug Fans

The showcase reinforced Regal Rexnord’s ongoing commitment to the Asia Pacific region under its “3P Strategy – Plant, Partner, and People.” With a strategic manufacturing base in Thailand, five factories in China, and sales subsidiaries across Singapore, Malaysia, and Thailand covering the entire Southeast Asia region, Regal Rexnord continues to strengthen its regional presence, distribution network, and responsiveness to customer needs.

Let us help you. Let us become your trusted partner. We believe our partnership will shape the neighboring data center space into a technology driven segment that delivers meaningful value to both our society and our world,Jane Yang added.

Stay updated on the latest innovations and industry insights by following us on LinkedIn at “Regal Rexnord Asia Pacific”

Vientiane to Deploy Over 2,000 Police Officers for That Luang Festival

Vientiane authorities will deploy more than 2,000 police officers to ensure safety and order during the That Luang Festival 2025, taking place from 1–5 November at That Luang and the Lao-ITECC Exhibition Center.

CGTN AMERICA & CCTV UN: Global Dialogue on Innovation, Openness and Shared Development

WASHINGTON, Oct. 23, 2025 /PRNewswire/ — CGTN America & CCTV UN releases “Global Dialogue on Innovation, Openness and Shared Development”

China Media Group will host a media event on Friday, October 24, at the Embassy of the People’s Republic of China in Washington, DC. The event, highlighting innovation, openness, and shared development, will bring together leading diplomats, commentators, and representatives of the young generation from China and the United States to discuss the outcomes and themes emerging from China’s Fourth Plenary Session, held in Beijing from October 20 to 23.

The plenary session reviews the proposals for formulating the 15th Five-Year Plan (2026-2030) for national economic and social development. It emphasizes high-quality development, technological self-reliance, green transformation, and the creation of a modern industrial system integrating digital, intelligent, and sustainable growth. The session also underscores the importance of education, science, and technology as engines of modernization, calling for stronger cultural confidence and enhanced global understanding through dialogue and exchange.

The upcoming media event will feature keynote speeches by officials and commentators from China and the United States, followed by a lively panel discussion with young voices exploring key global themes — including global governance, Chinese modernization, artificial intelligence and technology, sustainability, climate change, and people-to-people exchanges. These conversations reflect the vision and aspirations of a new generation committed to shaping a more inclusive and forward-looking world.

From 2021 to 2024, China’s economy has grown at an average annual rate of 5.5%, contributing nearly 30% of global growth while advancing green development, innovation, and openness. The discussion aims to offer fresh insight into how these achievements and emerging policy directions can support inclusive and sustainable global progress.

(This material is distributed by MediaLinks TV, LLC on behalf of CCTV. Additional information is available at the Department of Justice, Washington, D.C.)

Contact : Distribution@cgtnamerica.com